BrEaST: Rising Star Research Award:
Mentor and Mentee Educational Program for HR2+/HER2- mBC
Learning objectives:
2. To collect insights from young researchers on potential problems and barriers they are currently facing while developing their independent projects.
3. To assess the needs and provide educational resources to young researchers to help them better understand how to structure new research groups.
2025
1 CE credit
Webinar 1: Challenges and Barriers in mBC
Join the discussion of effectiveness of the main combination of CDK4/6i + ET vs. ET alone.
2025
1 CE credit
Webinar 2: Current First-line Treatments for HR+/HER2- mBC
Join the discussion of endocrine therapy combined with targeted therapies: recommendations for the first line including aromatase inhibitors or fulvestrant combined with CDKis.
2025
1 CE credit
Webinar 3: Current Treatments for HR+/HER2- mBC – Second and Subsequent-lines
Learn the role and perspectives of elacestrant, mTOR, PI3K, and AKT inhibitors in mBC treatment.
2025
1 CE credit
Webinar 4: Emerging and New Treatments for HR+/HER2- mBC
Join the discussion of novel/emerging endocrine therapies and targeted agents.
2025
1 CE credit
Webinar 5: Clinical Trial Optimization Current Treatments for HR+/HER2- mBC – Second and Subsequent-lines
Join the discussion of Pharmacovigilance, Protocol Development, and Adaptive Trial Development.
2025
1 CE credit
Webinar 5: The Role of Biomarkers in the Treatment Strategy for mBC
Learn about various biomarkers and guidelines to evaluate their role in identifying personalized treatment for each unique HR+/HER2- metastatic breast cancer patient.
